Drawing for ACTAVIS

USPTO serial 85951480

ACTAVIS

Reviewed by CopyMark Law Group

Reg. 4694086Status 710
Filing date
Status date
Registration date
Mar 3, 2015
Examiner
BRECKENFELD, WILLIAM G
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with ACTAVIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

GABRIELLE S. ROTH

GABRIELLE S ROTH SUGHRUE MION PLLC2100 PENNSYLVANIA AVENUE NWWASHINGTON, DC 20037UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Generic pharmaceuticals, namely, preparations and substances for the prevention and treatment of alimentary tract and metabolic diseases and disorders, dermatological diseases and disorders, genito-urinary and sexual diseases and disorders, musculo-skeletal system diseases and disorders, nervous system diseases and disorders, respiratory system diseases and disorders, cardio-vascular diseases and disorders, specifically excluding tissue plasminogen activators, sensory organ diseases and disorders, systemic hormonal pharmaceutical preparations and substances, pharmaceuticals, namely, anti-infectives, pharmaceutical preparations, namely, antineoplastic and immunomodulating agents, antiparasitic preparations and substances; all the foregoing specifically excluding tissue plasminogen activatorsSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 8, 2021C8..CANCELLED SEC. 8 (6-YR)—
Mar 3, 2020REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Feb 22, 2017ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Mar 3, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 22, 2015TMBNTTAB RELEASE CASE TO TRADEMARKS—
Jan 22, 2015OP.TOPPOSITION TERMINATED NO. 999999—
Jan 22, 2015OP.DOPPOSITION DISMISSED NO. 999999—
Apr 24, 2014OP.IOPPOSITION INSTITUTED NO. 999999—
Nov 25, 2013ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Nov 6, 2013ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 6, 2013REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 30, 2013NPUBNOTICE OF PUBLICATION—
Oct 29, 2013NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 29, 2013PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 9, 2013NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 18, 2013CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 18, 2013DOCKASSIGNED TO EXAMINER—
Jun 14, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 8, 2013NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance